Pharma companies invest billions in psychedelic drug research
Despite regulatory hurdles, pharmaceutical researchers remain optimistic about developing mind-altering drugs to treat depression and mood disorders.
Despite regulatory hurdles, pharmaceutical researchers remain optimistic about developing mind-altering drugs to treat depression and mood disorders.